This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
biofuels: Archive
5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes
by Supriyo Bose
MPLX, LDOS, JAZZ, FTNT and PPC are some of the stocks with high ROE to profit from as markets falter on tariff concerns.
JAZZNegative Net Change PPCNegative Net Change FTNTPositive Net Change MPLXPositive Net Change LDOSNegative Net Change
aerospace biofuels biotechnology consumer-discretionary tech-stocks
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales
by Zacks Equity Research
Pacira stock gains 11% on better-than-expected preliminary Q4 sales figures. It also shares a strategic growth plan to drive innovation and value creation by 2030.
HALONegative Net Change PCRXNegative Net Change CTMXNegative Net Change CSTLNegative Net Change
biofuels biotechnology medical pharmaceuticals
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term
by Nalak Das
These five geonomics and synthetic biology stocks are likely to soar in the short-term. They Are: CRSP, IMCR, GLUE, RIGL, CSTL.
RIGLNegative Net Change CRSPNegative Net Change CSTLNegative Net Change IMCRNegative Net Change GLUENegative Net Change
biofuels biotechnology
2 Momentum Anomaly Picks as Solid Earnings Boost Markets
by Supriyo Bose
CRS and AROC are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
CRSNegative Net Change AROCPositive Net Change
basic-materials biofuels
Buy 5 High ROE Stocks as Low Inflation Data Steadies Market
by Supriyo Bose
Upbound Group (UPBD), AES Corporation (AES), Arch Capital (ACGL), PulteGroup (PHM) and Banco de Chile (BCH) are some of the stocks with high ROE to profit as markets inch closer to all-time highs reached in mid-July.
PHMNegative Net Change AESNegative Net Change BCHNegative Net Change ACGLNegative Net Change UPBDNegative Net Change
biofuels business-services construction fin-tech finance
Cytokinetics (CYTK) Q2 Loss Wider Than Expected, Pipeline in Focus
by Zacks Equity Research
Cytokinetics (CYTK) reports wider-than-expected Q2 loss as operating expenses increase. CYTK is on track to complete the rolling NDA submission for aficamten in the third quarter.
RPRXNegative Net Change CYTKNegative Net Change ANIXNegative Net Change TRDANegative Net Change
biofuels biotechnology earnings medical pharmaceuticals
5 High ROE Stocks to Buy as Low Inflation Fuels Rate Cut Hopes
by Supriyo Bose
United Therapeutics (UTHR), ABB (ABBNY), Lockheed Martin (LMT), MPLX (MPLX) and Banco de Chile (BCH) are some of the stocks with high ROE to profit from as easing inflationary pressures ignite rate cut hopes.
LMTNegative Net Change UTHRPositive Net Change BCHNegative Net Change MPLXPositive Net Change ABBNYPositive Net Change
aerospace biofuels biotechs finance oil-energy tech-stocks
5 High ROE Stocks to Bet on as Markets Remain on Tenterhooks
by Supriyo Bose
Iron Mountain (IRM), Suzano (SUZ), PulteGroup (PHM), TE Connectivity (TEL) and Valero (VLO) are some of the stocks with high ROE to profit from as markets remain on the edge before Fed policy meeting.
IRMPositive Net Change VLOPositive Net Change PHMNegative Net Change TELPositive Net Change SUZNegative Net Change
biofuels business-services fin-tech tech-stocks
5 High ROE Stocks to Buy as Solid Bond Yields Hit Markets
by Supriyo Bose
Iron Mountain (IRM), MPLX, PulteGroup (PHM), META and W. R. Berkley (WRB) are some of the stocks with high ROE to profit from as high bond yields hit equity markets hard.
IRMPositive Net Change WRBNegative Net Change PHMNegative Net Change MPLXPositive Net Change METANegative Net Change
biofuels business-services construction insurance social-media
Uranium is the Future: Here's Why Bulls are in Control
by Andrew Rocco
World governments want lower greenhouse gas emissions while global energy consumption soars - a good recipe for Uranium bulls.
CCJNegative Net Change URNMNegative Net Change
alt-energy artificial-intelligence biofuels energy